# Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's Lymphoma

> **NCT00064116** · PHASE3 · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 824 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** rituximab
- **DRUG:** CHOP regimen

## Key facts

- **NCT ID:** NCT00064116
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05-08
- **Primary completion:** 2010-12
- **Final completion:** 2014-01-16
- **Target enrollment:** 824 (ACTUAL)
- **Last updated:** 2020-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00064116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00064116, "Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00064116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*